Skip to main content
. 2017 Sep 28;8(54):92366–92374. doi: 10.18632/oncotarget.21310

Table 2. Scr, Cystatin C and eGRF levels after 1 day of treatment.

Male Female Total
Scr at 1 day
 group A 0 0 0
 group B 2.63 (1.51, 3.83) 0.041 2.79 (2.42, 4.77) 0.033 2.64 (2.47, 4.98) 0.037
Cystatin C at 1 day
 group A 0 0 0
 group B 2.57 (2.26, 5.76) 0.041 2.99 (2.43, 4.77) 0.009 2.66 (2.62, 5.77) 0.022
eGRF at 1 day
 group A 0 0 0
 group B 4.25 (2.03, 5.92) 0.030 3.06 (2.38, 4.44) 0.000 4.02 (3.02, 5.53) 0.037

Results are presented as OR (95% CI) P value.

Adjust for: smoking, previous MI, albumin, HDL-C, iodixanol dosage, ACEIs/ARBs, beta-blockers and GPIIb/IIIa inhibitors.

MI=myocardial infarction, HDL-C=High density lipoprotein; ACEIs=Angiotensin-converting enzyme inhibitors; ARBs=Angiotensin-receptor blockers; GPIIb/IIIa inhibitors=Glycoprotein IIb/IIIa inhibitors; NS=Not significant.